Process for the reduction in microbial activity in protein product chilled water cooling tanks for increased tank water utility and conservation

1. A process for extending the use of water during the production of products for human consumption comprising:

predetermining an amount of peracetic acid required in a chiller tank system at the start of a first production day to provide a starting concentration of about 10 ppm to about 230 ppm of peracetic acid in an aqueous solution;

delivering an initial amount of peracetic acid to the chiller tank system to provide the starting concentration of about 10 ppm to about 230 ppm of aqueous peracetic acid solution within the chiller tank system;

allowing a first product for human consumption to come in contact with the aqueous peracetic acid solution during a first production day;

determining appropriate concentrations of peracetic acid within the chiller tank system during the first production day;

adding additional peracetic acid to the chiller tank system to maintain an acceptable concentration of about 10 ppm to about 230 ppm of the aqueous peracetic acid solution in the chiller tank system during the first production day;

shutting down production using the chiller tank system at the end of the first production day;

retaining the remaining aqueous peracetic acid solution within the chiller tank system at a temperature lower than ambient temperature at the end of the first production day;

recharging the aqueous peracetic acid solution retained within the chiller tank system to the starting concentration of about 10 ppm to about 230 ppm of the aqueous peracetic acid solution at the beginning of a next production day;

shutting down the chiller tank system at the end of the next production day; and

draining the chiller tank system;

wherein the steps of shutting down the chiller tank system, retaining the remaining aqueous peracetic acid solution within the chiller tank system, and recharging the aqueous peracetic acid solution retained within the chiller tank system to the starting concentration at the beginning of the next production day, can be repeated to provide up to seven production days before conducting the step of draining the water tank system.

2. The process of claim 1 , wherein the step of predetermining the amount of peracetic acid required is achieved by sensing probes or chemical titration testing.

3. The process of claim 1 , wherein the step of recharging the aqueous peracetic acid solution, further comprises predetermining an amount of peracetic acid required by sensing probes or chemical titration testing to recharge the aqueous acid solution retained within the chiller tank system to the starting concentration at the beginning of the next production day, delivering a concentrated amount of peracetic acid to a makeup water supply, and delivering the makeup water supply containing the peracetic acid to the chiller tank system.

4. The process of claim 1 , further comprising cleaning the chiller tank system, rinsing the chiller tank system, sanitizing the chiller tank system, or combinations thereof, after the draining step.

5. The process of claim 1 , wherein the starting concentration of the aqueous peracetic acid solution is between about 10 ppm and about 140 ppm at the beginning of at least one of the respective production days.

6. A process for extending the use of water during the production of products for human consumption comprising:

providing a chiller tank system with a process volume of an aqueous antimicrobial intervention solution, the aqueous antimicrobial intervention solution comprising peracetic acid at a predetermined initial chemical concentration of about 10 ppm to about 230 ppm;

allowing a product for human consumption to come in contact with the aqueous antimicrobial intervention solution during a first production day;

maintaining an acceptable concentration of about 10 ppm to about 230 ppm of peracetic acid in the aqueous antimicrobial intervention solution during the first production day;

shutting down production using the chiller tank system at the end of the first production day;

retaining the remaining aqueous antimicrobial intervention solution within the chiller tank system at a temperature lower than ambient temperature at the end of the first production day;

recharging the process volume comprising the aqueous antimicrobial intervention solution retained within the chiller tank system to a second predetermined chemical concentration of about 10 ppm to about 230 ppm of peracetic acid at the beginning of a next production day;

allowing a product for human consumption to come in contact with the aqueous antimicrobial intervention solution during the next production day;

maintaining an acceptable concentration of about 10 ppm to about 230 ppm of peracetic acid in the aqueous antimicrobial intervention solution during the next production day; and

draining the aqueous antimicrobial intervention solution from the chiller tank system;

wherein the steps of shutting down the chiller tank system, retaining the remaining aqueous antimicrobial intervention solution within the chiller tank system, and recharging the process volume of the aqueous antimicrobial intervention solution in the chiller tank system to the predetermined chemical concentration of peracetic acid at the beginning of the next production day, can be repeated up to five additional times to provide up to seven production days before conducting the step of draining the aqueous antimicrobial intervention solution from the chiller tank system.

7. The process of claim 6 , wherein the predetermined initial chemical concentration of peracetic acid at the beginning of any of the production days is between about 10 ppm and about 140 ppm.

8. The process of claim 7 , wherein any of the steps of maintaining an acceptable concentration of peracetic acid in the aqueous antimicrobial intervention solution during any of the respective production days is between about 10 ppm and about 140 ppm.

9. The process of claim 8 , wherein any of the steps of maintaining an acceptable concentration of peracetic acid in the aqueous antimicrobial intervention solution during any of the respective production days, further comprises conducting a chemical titration test to determine the concentration of peracetic acid in the process volume; and adding peracetic acid to the process volume based on a result of the chemical titration test to maintain the acceptable concentration of peracetic acid in the aqueous antimicrobial intervention solution.

10. The process of claim 8 , wherein any of the steps of maintaining an acceptable concentration of peracetic acid in the aqueous antimicrobial intervention solution during any of the respective production days, further comprises using sensors to provide sensor data about a working concentration of peracetic acid in the process volume; and adding peracetic acid to the process volume based on the sensor data to maintain the acceptable concentration of peracetic acid in the aqueous antimicrobial intervention solution.

11. The process of claim 10 , wherein the step of adding peracetic acid to the process volume to maintain the acceptable concentration of peracetic acid, further comprises delivering a concentrated amount of peracetic acid within a makeup water supply to the chiller tank system.

12. The process of claim 6 , wherein the acceptable concentration of peracetic acid in the aqueous antimicrobial intervention is maintained between about 10 ppm and 230 ppm.

13. The process of claim 6 , wherein the steps of shutting down the chiller tank system, retaining the remaining aqueous antimicrobial intervention solution within the chiller tank system, and recharging the process volume of the aqueous antimicrobial intervention solution in the chiller tank system to the predetermined chemical concentration of peracetic acid, are not repeated such that there are two production days provided before conducting the step of draining the aqueous antimicrobial intervention solution from the chiller tank system.

14. The process of claim 6 , wherein the steps of shutting down the chiller tank system, retaining the remaining aqueous antimicrobial intervention solution within the chiller tank system, and recharging the process volume of the aqueous antimicrobial intervention solution in the chiller tank system to the predetermined chemical concentration of peracetic acid at the beginning of the next production day, are each repeated at least once and up to five additional times such that there are at least three production days and up to seven production days provided before conducting the step of draining the aqueous antimicrobial intervention solution from the chiller tank system.

15. The process of claim 14 , further comprising allowing a product for human consumption to come in contact with the aqueous antimicrobial intervention solution during each of the respective production days, wherein the products for human consumption for each of the respective production days are not the same product but are the same type of product.

16. The process of claim 14 , further comprising maintaining an acceptable concentration between about 10 ppm and about 140 ppm of peracetic acid in the aqueous antimicrobial intervention solution during each of the respective production days.

17. The process of claim 6 , wherein the step of recharging the process volume, further comprises predetermining an amount of peracetic acid required by sensing probes or chemical titration testing to recharge the process volume retained within the chiller tank system to the predetermined initial chemical concentration at the beginning of the next production day, delivering a concentrated amount of peracetic acid to a makeup water supply, and delivering the makeup water supply containing the peracetic acid to the chiller tank system.

18. A process for extending the use of water during the production of one or more products for human consumption comprising:

providing a starting concentration of about 10 ppm to about 230 ppm of an aqueous peracetic acid solution within a chiller tank system during a first production day;

placing a product for human consumption into the aqueous peracetic acid solution during a first production day;

removing the product for human consumption from the aqueous peracetic acid solution during the first production day;

shutting down production using the chiller tank system at the end of the first production day;

retaining the remaining aqueous peracetic acid solution within the chiller tank system at a temperature lower than ambient temperature after shutting down the chiller tank system at the end of the first production day;

recharging the aqueous peracetic acid solution retained within the chiller tank system to the starting concentration of about 10 ppm to about 230 ppm of aqueous peracetic acid solution within the chiller tank system at the beginning of a next production day;

placing a product for human consumption into the aqueous peracetic acid solution during a next production day;

removing the product for human consumption from the aqueous peracetic acid solution during the next production day;

shutting down the chiller tank system at the end of the next production day; and

draining the chiller tank system;

wherein the steps of shutting down the chiller tank system, retaining the remaining aqueous peracetic acid solution within the chiller tank system, and recharging the aqueous peracetic acid solution retained within the chiller tank system to the starting concentration at the beginning of the next production day, can be repeated to provide up to seven production days before conducting the step of draining the chiller tank system.

19. The process of claim 18 , wherein the steps of shutting down the chiller tank system, retaining the remaining aqueous antimicrobial intervention solution within the chiller tank system, and recharging the process volume of the aqueous antimicrobial intervention solution in the chiller tank system to the predetermined chemical concentration of peracetic acid at the beginning of the next production day, are each repeated at least once and up to five times such that there are at least three production days and up to seven production days provided before conducting the step of draining the chiller tank system.

20. The process of claim 19 , further comprising maintaining an acceptable concentration of about 10 ppm to about 230 ppm of peracetic acid in the aqueous antimicrobial intervention solution during each of the respective production days.